0000899243-21-005129.txt : 20210208
0000899243-21-005129.hdr.sgml : 20210208
20210208140131
ACCESSION NUMBER: 0000899243-21-005129
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210204
FILED AS OF DATE: 20210208
DATE AS OF CHANGE: 20210208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Omega Fund V, L.P.
CENTRAL INDEX KEY: 0001641354
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38940
FILM NUMBER: 21600738
BUSINESS ADDRESS:
STREET 1: 888 BOYLSTON ST., SUITE 1111
CITY: BOSTON
STATE: MA
ZIP: 02199
BUSINESS PHONE: 617-502-6538
MAIL ADDRESS:
STREET 1: 888 BOYLSTON ST., SUITE 1111
CITY: BOSTON
STATE: MA
ZIP: 02199
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Omega Fund V GP, L.P.
CENTRAL INDEX KEY: 0001641355
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38940
FILM NUMBER: 21600739
BUSINESS ADDRESS:
STREET 1: 888 BOYLSTON ST., SUITE 1111
CITY: BOSTON
STATE: MA
ZIP: 02199
BUSINESS PHONE: 617-502-6538
MAIL ADDRESS:
STREET 1: 888 BOYLSTON ST., SUITE 1111
CITY: BOSTON
STATE: MA
ZIP: 02199
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Omega Fund V GP Manager, Ltd.
CENTRAL INDEX KEY: 0001641348
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38940
FILM NUMBER: 21600740
BUSINESS ADDRESS:
STREET 1: 888 BOYLSTON ST., SUITE 1111
CITY: BOSTON
STATE: MA
ZIP: 02199
BUSINESS PHONE: 617-502-6538
MAIL ADDRESS:
STREET 1: 888 BOYLSTON ST., SUITE 1111
CITY: BOSTON
STATE: MA
ZIP: 02199
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stampacchia Otello
CENTRAL INDEX KEY: 0001361712
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38940
FILM NUMBER: 21600741
MAIL ADDRESS:
STREET 1: 888 BOYLSTON ST., SUITE 1111
CITY: BOSTON
STATE: MA
ZIP: 02199
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Morphic Holding, Inc.
CENTRAL INDEX KEY: 0001679363
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473878772
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 9787296480
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Morphic Holding, LLC
DATE OF NAME CHANGE: 20160712
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-04
0
0001679363
Morphic Holding, Inc.
MORF
0001641354
Omega Fund V, L.P.
888 BOYLSTON STREET, SUITE 1111
BOSTON
MA
02199
1
0
0
0
0001641355
Omega Fund V GP, L.P.
888 BOYLSTON STREET, SUITE 1111
BOSTON
MA
02199
1
0
0
0
0001641348
Omega Fund V GP Manager, Ltd.
888 BOYLSTON STREET, SUITE 1111
BOSTON
MA
02199
1
0
0
0
0001361712
Stampacchia Otello
888 BOYLSTON STREET, SUITE 1111
BOSTON
MA
02199
1
0
0
0
Common Stock
2021-02-04
4
S
0
4574
37.95
D
2684746
D
Common Stock
2021-02-04
4
S
0
4963
38.55
D
2679783
D
Common Stock
2021-02-05
4
S
0
5734
37.78
D
2674049
D
Common Stock
2021-02-05
4
S
0
147
38.40
D
2673902
D
Shares were sold pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.37 to $38.34 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.37 to $38.89 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.09 to $38.04 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.39 to $38.42 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The reported securities are held directly by Omega Fund V, L.P. ("Omega V"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V GP, L.P. ("Omega V GP"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. ("Omega V GP Manager"), as the general partner of Omega V GP. Otello Stampacchia, Anne-Mari Paster and Claudio Nessi (the "Omega Directors") are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Each of Omega V GP, Omega Fund V GP Manager and the Omega Directors disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any. Otello Stampacchia is a director of the issuer.
/s/ Anne-Mari Paster, as an authorized signatory of each Reporting Person
2021-02-08